Afrezza 4U Inhalation Cartridge 30S

Afrezza 4U Inhalation Cartridge 30S

Prescription drug
Manufacturer / Marketer : ETABX
Expiry : 29-02-2028
About: Afrezza is rapid-acting inhaled human insulin indicated to improve glycemic control in adult patients with diabetes mellitus.Usage Instructions: Inhale at beginning of each meal using Afrezza inhaler. One 4U cartridge per meal for mealtime insulin coverage. Prime inhaler before first use.Benefits: Rapid onset of action, convenient non-injectable insulin, improves postprandial glucose control, flexible mealtime dosing.How it Works: Inhaled insulin is rapidly absorbed through alveolar membrane into bloodstream, providing prandial insulin coverage similar to rapid-acting injectable insulin.Side Effects: Cough, throat irritation, hypoglycemia, decreased lung function, bronchospasm (in asthmatics), weight gain.Safety Advice: Contraindicated in chronic lung disease (asthma, COPD). Monitor lung function before starting and periodically. Not for DKA treatment. Carry glucose for hypoglycemia.Storage: Refrigerate at 2-8°C. Do not freeze. Once in use, store at room temperature for up to 10 days. Protect from light.
₹3,799.05 MRP: ₹3,999.00 Save ₹199.95 (5%)
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
About: Afrezza is rapid-acting inhaled human insulin indicated to improve glycemic control in adult patients with diabetes mellitus.Usage Instructions: Inhale at beginning of each meal using Afrezza inhaler. One 4U cartridge per meal for mealtime insulin coverage. Prime inhaler before first use.Benefits: Rapid onset of action, convenient non-injectable insulin, improves postprandial glucose control, flexible mealtime dosing.How it Works: Inhaled insulin is rapidly absorbed through alveolar membrane into bloodstream, providing prandial insulin coverage similar to rapid-acting injectable insulin.Side Effects: Cough, throat irritation, hypoglycemia, decreased lung function, bronchospasm (in asthmatics), weight gain.Safety Advice: Contraindicated in chronic lung disease (asthma, COPD). Monitor lung function before starting and periodically. Not for DKA treatment. Carry glucose for hypoglycemia.Storage: Refrigerate at 2-8°C. Do not freeze. Once in use, store at room temperature for up to 10 days. Protect from light.

Related Products